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Abstract
The use of environmental DNA (eDNA) analysis for species monitoring requires rigor-
ous validation— from field sampling to the analysis of PCR- based results— for mean-
ingful application and interpretation. Assays targeting eDNA released by individual 
species are typically validated with no predefined criteria to answer specific research 
questions in one ecosystem. Hence, the general applicability of assays, as well as 
associated uncertainties and limitations, often remain undetermined. The absence 
of clear guidelines for assay validation prevents targeted eDNA assays from being 
incorporated into species monitoring and policy; thus, their establishment is essential 
for realizing the potential of eDNA- based surveys. We describe the measures and 
tests necessary for successful validation of targeted eDNA assays and the associ-
ated pitfalls to form the basis of guidelines. A list of 122 variables was compiled, 
consolidated into 14 thematic blocks (e.g., “in silico analysis”), and arranged on a 
5- level validation scale from “incomplete” to “operational” with defined minimum 
validation criteria for each level. These variables were evaluated for 546 published 
single- species assays. The resulting dataset was used to provide an overview of cur-
rent validation practices and test the applicability of the validation scale for future 
assay rating. Of the 122 variables, 20% to 76% were reported; the majority (30%) of 
investigated assays were classified as Level 1 (incomplete), and 15% did not achieve 
this first level. These assays were characterized by minimal in silico and in vitro test-
ing, but their share in annually published eDNA assays has declined since 2014. The 
meta- analysis demonstrates the suitability of the 5- level validation scale for assess-
ing targeted eDNA assays. It is a user- friendly tool to evaluate previously published 
assays for future research and routine monitoring, while also enabling the appropri-
ate interpretation of results. Finally, it provides guidance on validation and reporting 
standards for newly developed assays.
K E Y W O R D S
digital PCR, eDNA, endpoint PCR, https://edna- validation.com, quantitative PCR, species 
detection, species- specific
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1  | INTRODUC TION
Determining the occurrence of species is essential for ecology and 
requires sensitive and accurate detection methods. Within the last 
decade, species detection from environmental DNA (eDNA; i.e., de-
tection of extra- organismal DNA released by organisms into their 
environment) has shown great potential for routine species surveys 
(Deiner et al., 2017; Goldberg et al., 2016; Langlois et al., 2020; Rees 
et al., 2014; Sepulveda et al., 2020). The interest in molecular species 
detection has fuelled the development of over 500 assays, reviewed 
herein, that utilize PCR to amplify DNA or RNA extracted from envi-
ronmental samples. Generally, “targeted” eDNA assays must be spe-
cific to the species of interest and possess high sensitivity to allow 
detection at low densities, low DNA concentrations, and across spa-
tiotemporal scales (Goldberg et al., 2016; MacDonald & Sarre, 2017).
A targeted eDNA assay encompasses the entire workflow used 
to detect a species’ DNA from an environmental sample, inclusive of 
field sampling through to the interpretation of PCR- based results; it 
does not just consist of the primers and probes. Thus, adherence to 
workflows will determine the success or failure of an eDNA assay 
because methodological choices influence performance and sensi-
tivity (e.g., Doi, Takahara, et al., 2015; Tsuji et al., 2019). In practice, 
assays are often validated within a specific system to answer a set 
question about the target species. Hence, applications beyond this 
initial development are hampered by the poor understanding of re-
maining uncertainties, such as the potential for false positives result-
ing from nontarget amplification or contamination, or false negatives 
resulting from low sensitivity, sample degradation, low DNA yield 
protocols, or inhibition (Goldberg et al., 2016; Lacoursière- Roussel 
& Deiner, 2021). In a management context, false positives and false 
negatives may lead to misuse of resources (e.g., funds and person-
nel) for issues such as rare species protection and invasive species 
control. Both scenarios foster inaccurate interpretation of results, 
fuelling arguments against the routine use of eDNA detection for 
species monitoring (Jerde, 2021).
Aside from a few well- validated eDNA assays already incorpo-
rated into routine monitoring, the application of published assays 
is a minefield for end- users to navigate. We illustrate this through 
two examples. The assay for great crested newt (Triturus crista-
tus (Laurenti, 1768), a legally protected species in the UK [Natural 
England, 2015]), was one of the first eDNA assays validated in both 
laboratory and field trials against conventional tools, demonstrat-
ing its potential for routine monitoring (Rees, Bishop, et al., 2014; 
Thomsen et al., 2012). After successful validation, a national eDNA- 
based citizen science monitoring scheme was tested and showed 
that large- scale eDNA sampling can enable distribution modeling 
(Biggs et al., 2015). These initial studies paved the way for eDNA- 
based T. cristatus detection to inform new policies aimed at provid-
ing landscape- level species protection (Harper, Buxton, et al., 2019). 
Studies have since investigated optimal methods of eDNA capture, 
relative abundance and detection probability estimation, and the in-
fluence of seasonality as well as biotic and abiotic factors on T. crista-
tus eDNA detection and quantification (Buxton et al., 2017; Buxton, 
Groombridge, & Griffiths, 2018a, 2018b; Buxton et al., 2017). Due to 
these combined efforts, the assay has undergone exemplary valida-
tion and has been operational for management since 2014.
Conversely, no assays have been successfully applied to rou-
tine monitoring of invasive American crayfish. For example, there 
is a lack of consensus on a single assay for the signal crayfish 
(Pacifastacus leniusculus (Dana, 1852)). Larson et al. (2017) developed 
and tested an assay against conventional trapping, but five other as-
says have also been proposed with differing degrees of validation 
and divergent in silico and in vitro approaches (Agersnap et al., 2017; 
Dunn et al., 2017; K. J. Harper et al., 2018; Mauvisseau et al., 2018; 
Robinson et al., 2018). The P. leniusculus assays were developed using 
a variety of strategies for eDNA sampling, capture, extraction, qPCR 
of different genetic markers, and applied across genetically diverse 
populations within the species range. Due to this substantial meth-
odological variability, direct comparisons between results obtained 
from these assays are impossible. Therefore, the P. leniusculus assays 
represent a minefield for end- users, despite the need for accurate 
and sensitive tools to enable actionable species management of this 
invasive species in Europe, Japan, and California (USA).
These case studies exemplify how consensus and dissent in 
assay validation can influence the implementation of eDNA analy-
sis for species monitoring. Developing guidelines to determine the 
suitability of eDNA assays for end- users will therefore ensure that 
ecological insights or management decisions are based on robust mo-
lecular analyses with quantifiable uncertainties and clear inference 
limits (Goldberg et al., 2016; MacDonald & Sarre, 2017; Nicholson 
et al., 2020; Sepulveda et al., 2020). Here, we describe the general 
validation process for targeted PCR- based methods and examine the 
extent of assay validation and reporting in the eDNA literature. We 
present an eDNA assay validation scale, which establishes criteria 
to enable the classification of assays based on their accuracy and 
sensitivity for single- species detection. To demonstrate the utility 
of the scale, we performed a meta- analysis of targeted eDNA assays 
published in 327 papers as of 11 April 2019 (546 assays). By placing 
an eDNA assay on the validation scale, end- users can determine the 
recommended scenarios for application and improve assay perfor-
mance with further validation.
2  | CRITERIA AND PRINCIPLES OF 
VALIDATION
2.1 | General requirements for an eDNA laboratory
All laboratory activities are subject to error. In order to have confi-
dence in results, quality standards and good practices are required 
in diagnostic laboratory environments (e.g., Halling et al., 2012; 
World Health Organization, 2011). Although few eDNA- processing 
laboratories will employ “ancient DNA” practices (e.g., full body suit 
and positive air pressure with HEPA filtered inflow), all laboratories 
conducting eDNA analysis should utilize a unidirectional work-
flow where pre- PCR steps are performed in separate laboratories 
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dedicated to low DNA quality and quantity (Goldberg et al., 2016). 
Completely standardized laboratory environments are rare, and 
the use of proficiency tests (as conducted by UK laboratories par-
ticipating in T. cristatus monitoring) can help end- users understand 
the quality of results obtained among different laboratories. Even 
results obtained from an extensively validated assay can be ques-
tionable when they are not produced within a suitable laboratory 
environment (Goldberg et al., 2016).
2.2 | Reporting standards for in silico, in vitro, and 
in situ validation of assays
Targeted eDNA assay validation is a multi- step process. It can be 
divided into in silico validation (i.e., computer- based tests for primer 
specificity), in vitro validation (i.e., laboratory tests with reference 
tissue samples), and in situ validation (i.e., field tests with eDNA sam-
ples) (see Goldberg et al., 2016; Langlois et al., 2020; MacDonald & 
Sarre, 2017; So et al., 2020). Understanding the utility of an assay re-
quires both knowledge of the context in which it has been designed, 
and a broader understanding of how it was developed. Here, we give 
a brief overview of what key steps comprise assay validation, with a 
focus on troubleshooting steps that may be necessary when apply-
ing previously published assays to new locations or with modified 
laboratory practices (Table 1).
The first step is in silico assay validation, the goal of which is 
to determine assay specificity based on known sequence diversity. 
Sequence diversity has three categories, including sequences from 
(a) closely related and co- occurring species, (b) closely related but 
geographically distinct species, and (c) distantly related but co- 
occurring species (i.e., sequences that could co- amplify and produce 
false positive results for a target species). By checking primer speci-
ficity from available sequences, the geographic area of applicability 
for an assay can be maximized through identifying and removing 
potential issues of co- amplification. Typically, public or custom da-
tabases are used for performing in silico amplification (e.g., ecoPCR 
[Boyer et al., 2016]; primerBlast [Ye et al., 2012]; PrimerTREE 
[Cannon et al., 2016]; PrimerMiner [Elbrecht & Leese, 2017]). While 
reference sequence libraries are often far from complete and many 
of the factors influencing successful PCR amplification cannot be 
simulated, in silico testing provides a first impression of primer per-
formance and should be conducted.
The essential components of in vitro assay validation are optimi-
zation, specificity, and sensitivity. Tests with varying PCR chemistry, 
reaction volume, primer/probe concentration, cycling conditions, and 
technical replication will ensure optimal, standardized, and error- free 
target DNA amplification (Bustin et al., 2009; Goldberg et al., 2016; 
Wilcox et al., 2015). The assay must then be tested against closely 
related and co- occurring nontarget taxa to ensure specificity, which 
is not automatically guaranteed after successful in silico testing 
(Goldberg et al., 2016; So et al., 2020). Ideally, tissue- derived DNA 
samples from multiple individuals spanning a defined geographic 
area are tested to ensure the assay is robust to genetic variants 
of target and nontarget species. Amplicons should be Sanger se-
quenced to confirm species identity (Goldberg et al., 2016), although 
short fragments (<100 bp) have limited sequence length available 
for species determination (Meusnier et al., 2008). Next, the Limit of 
Detection (LOD) must be determined to assess assay sensitivity, and 
the Limit of Quantification (LOQ) determined, if the measurement of 
eDNA quantity is desired. Generally, these values are obtained using 
a dilution series of quantified DNA amplicons or synthesized gene 
fragments (e.g., IDT gBlocks™ Gene Fragment) based on public or de 
novo reference sequences (Langlois et al., 2020). The LOD and LOQ 
have various definitions in the eDNA literature, but were recently 
standardized by Klymus et al. (2019), where LOD is the lowest stan-
dard concentration at which 95% of technical replicates amplify and 
LOQ is the lowest standard concentration for which the coefficient 
of variation (CV) value is <35%. Unfortunately, the existence of past 
definitions requires the final LOD and LOQ to be reported as well as 
the definition used. We note that these metrics apply directly to the 
assay as developed and assume no interference during PCR from the 
rest of the species’ genome (i.e., if a gBlock is used), other genetic 
material, or inhibitory compounds.
Finally, the assay must be validated in situ by surveying sites 
with and without the target species (Goldberg et al., 2016). It must 
be tested against conventional tools for presence/absence detec-
tion and tests for estimation of relative abundance/biomass are 
advisable. Assays are deemed successful if eDNA and conventional 
detections concur at occupied sites, and no eDNA detections are ob-
served at definitively unoccupied sites. Sanger sequencing of eDNA 
amplicons can provide additional evidence but cannot distinguish 
sample contamination from true detections (Goldberg et al., 2016). 
Besides screening for the target species, negative eDNA samples (or 
all eDNA samples if quantification is necessary) should be tested for 
inhibition. This requires an internal positive control (IPC) assay for 
synthetic DNA (e.g., ThermoFisher) or an assay for nontarget spe-
cies using exogenous or endogenous DNA (Doi et al., 2017; Furlan & 
Gleeson, 2017; Goldberg et al., 2016; Veldhoen et al., 2016).
Advanced in situ validation may investigate the influence of biotic 
(e.g., abundance, biomass, life stages, microbial activity) and abiotic 
(e.g., temperature, pH, ultraviolet light, salinity) factors influenc-
ing eDNA origin, state, fate, and transport (Barnes & Turner, 2016; 
Lacoursière- Roussel & Deiner, 2021; Wang et al., 2021). Assays that 
account for spatial (e.g., shoreline vs. offshore) and temporal (e.g., 
summer vs. winter) variation in eDNA distribution and abundance 
due to the ecology of a species can be implemented with greater 
confidence (Lawson Handley et al., 2019; de Souza et al., 2016). 
Occupancy modeling using eDNA data is desirable as it accounts 
for detection probability while estimating site occupancy, even if all 
field samples from a site return negative. Hierarchical models that 
incorporate eDNA occupancy and detection probabilities at site, 
sample, and technical replicate levels are most accurate and can be 
implemented in software such as R (e.g., package “eDNAoccupancy” 
[Dorazio & Erickson, 2018]) or PRESENCE (MacKenzie et al., 2002). 
However, model assumptions regarding false positives should be 
carefully considered.
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TA B L E  1   A guideline for troubleshooting at different stages of the validation process
General issues In silico validation In vitro validation In situ validation
Applying assay to a new 
geographic location
Test nontarget sequences available 
on public/custom databases from 
this location
Test tissue from nontarget species 
present at this location, including 
species present at original location 
if populations are genetically 
diverse
Test assay at sites where new, 
potentially problematic nontarget 
species are known to occur
Sparse reference data If possible, Sanger sequence tissue 
DNA from target and nontarget 
species to generate reference 
sequences
Extensively test assay on tissue 
available for target and nontarget 
species, that is, test extracts from 
multiple individuals
Extensively test assay at sites where 
target species co- occurs with 
nontarget species lacking reference 
sequences, and at sites where only 
nontarget species lacking reference 
sequences occur
In vitro validation 
issues Troubleshooting guidelines In situ validation issues Troubleshooting guidelines
Poor amplification 
efficiency
Optimize reaction volume Expected species presence/absence 
not confirmed
Survey sites with conventional 
tools and eDNA metabarcoding if 
possible
Optimize cycle number
Optimize primer- probe 
concentration
False positives Discard samples corresponding to 
contaminated controls; consider 
lack of specificity; Sanger sequence 
results
Optimize annealing temperature 
using gradient PCR
Optimize technical replication Resample with more stringent 
decontamination measures in place
Check pipetting accuracy
Poor specificity Increase annealing temperature False negatives Check for inhibition and treat 
samples if inhibited; consider timing 
and spacing of sampling
Add hydrolysis probe
Perform melting curve analysis Increase technical replication
Try other enzymes (e.g., EMM) Resample and increase biological 




(see also Klymus 
et al., 2019)
Ensure enough replication of fresh 
standards used when establishing 
the Limit of Detection
Poor quality Sanger sequencing Purify amplicons prior to sequencing
Use TE buffer and tRNA to make 
standard dilutions, not molecular 
grade water
Concentrate amplicons prior to 
sequencing
Use low retention tubes and pipette 
tips when preparing standards to 
prevent adsorption to plastic
Inhibition (determined by failed/
skewed amplification of IPC or 
nontarget assay)
Use a DNA extraction kit that 
includes an inhibitor removal step 
(e.g., mu- DNA, Qiagen QIAamp 
DNA Stool Mini Kit, Qiagen 
DNeasy PowerWater Kit, Qiagen 
DNeasy PowerSoil Kit)
If possible, switch to PCR platform 
with greater sensitivity
Apply an inhibitor removal kit (e.g., 
OneStep Inhibitor Removal Kit, 
Zymo Research Corp.) to samples
Consider redesign Use PCR reagents designed to 
handle inhibition (e.g., TaqMan 
Environmental Master Mix, Bovine 
Serum Albumin)
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3  | T YPES AND TR ADE-  OFFS OF 
TARGETED EDNA DETEC TION METHODS
Amid the processing chain (i.e., sampling to data analysis) for a tar-
geted eDNA assay, PCR warrants extra consideration as the techno-
logical spectrum and potential for variation is enormous. Previous 
publications have typically defined an assay as the primers (and 
probe) required for DNA amplification and associated visualization 
(e.g., agarose gel electrophoresis, qPCR instrumentation). However, 
differences between the multiple detection instruments and chem-
istry used in combination with species- specific primer (and probe) 
sets can fundamentally change the sensitivity and specificity of tar-
geted eDNA assays. Table 2 provides an overview of amplification 
types and their associated trade- offs.
Many assays— especially those published in earlier years— use 
endpoint PCR. However, most assays to date employ real- time quan-
titative (q)PCR allowing for greater sensitivity and quantitative data. 
More recent publications have used digital (d)PCR for absolute quan-
tification. Alternatively, LAMP and CRISPR have been shown to be 
suitable for eDNA applications, decreasing the requirements of in- 
field testing equipment (Williams et al., 2017; Williams et al., 2019). 
A few publications use alternative methods such as PCR combined 
with restriction fragment length polymorphism (RFLP). All amplifi-
cation types (Table 2) enable distribution and occupancy modeling, 
provided enough biological and technical replication is employed 
(Goldberg et al., 2018; Hunter et al., 2015; Wilcox et al., 2018). 
However, endpoint PCR in combination with agarose gels is the only 
type for which a detection limit cannot be set objectively (low sen-
sitivity) and which does not provide estimates of DNA copy number 
(Doi, Uchii, et al., 2015; Hunter et al., 2017; Thalinger et al., 2019; 
Yamanaka & Minamoto, 2016). Depending on the management con-
text and study size, the optimal detection instrument can vary, albeit 
technological advances and required accuracy will continue to shift 
the focus away from endpoint PCR.
4  | E VALUATING THE CURRENT STATUS 
OF A SSAY VALIDATION
To understand current validation practices for targeted eDNA as-
says, we generated an extensive list of variables deemed important 
for assay validation by 35 experts in the field of targeted eDNA de-
tection whom convened at a DNAqua- Net EU COST Action (Leese 
et al., 2016) workshop held on 26– 27 March 2018 at the University 
of Innsbruck, Austria. The variables in this list consist of 18 nominal 
or categorical variables (e.g., species identity, target gene, sample 
type) and 104 binary variables directly associated with the eDNA- 
processing chain, from primer design to interpretation of field study 
results (Appendix S1).
A comprehensive literature database for targeted eDNA assays 
was built in three steps. First, we included all papers listed on the 
“eDNA assays” web page (https://labs.wsu.edu/edna/edna- assay 
s/) as of 10 April 2019. Second, we conducted a Web of Science 
literature search on 11 April 2019, including the search terms “en-
vironmental DNA” and “eDNA” but excluding terms associated with 
microbial organisms and metabarcoding (Appendix S2). Third, the 
resulting 660 Web of Science entries were manually checked for 
suitability (i.e., macrobial target organism, targeted eDNA detection 
intended) leading to a combined database of 327 papers. For each 
of the assays contained in these papers, the 122 variables were re-
corded in a checklist by one of the authors. Before data entry, all 
authors validated the same four papers (Deiner & Altermatt, 2014; 
Rees, Bishop, et al., 2014; Thalinger et al., 2016; Harper, Griffiths, 
et al., 2019) to ensure recorder standardization. Validation efforts 
were classified as 1 for “tests done, or parameter reported,” 0 for 
“variable not reported, or no testing done,” and NA in cases where 
the respective variable did not match the assay type (e.g., filter type 
when samples were precipitated). When an assay was used in mul-
tiple papers, all validation efforts were summarized in one entry 
and the literature database was extended with the papers reporting 
primer sequences or other methodological aspects. As the type of 
amplification is important for assay validation, primer pairs used on 
multiple detection platforms were given separate database entries 
per amplification type. However, because most assays developed 
were presented in one publication, we did not account for slight 
variations in other aspects of the workflow (e.g., different extraction 
method, different filter type). After recording the values for each 
eDNA assay using the validation checklist (Appendix S1), each au-
thor scored the assay intuitively based on a preliminary version of 
the validation scale (see Section 5). The resulting database of 122 
variables for each assay was the basis for all further analyses using R 
(R Core Team, 2020) and associated packages (Appendix S2).
Altogether, 546 assays from 327 papers were assessed. Of these 
assays, 227 were designed to detect fish species and 74 were de-
signed to detect amphibian species; hence, it is unsurprising that 
~80% of assays utilized water sampling. Fourteen percent of the as-
says were tested on tissue only and few assays were optimized for 
other sample types such as aerosol, sediment, snow, or soil. More 
than 80% of assays were reported in only one paper, and most were 
designed for qPCR (~60%) or endpoint PCR (~35%) platforms. The 
cytochrome c oxidase subunit I (COI) gene was the most popular 
(>40%) genetic marker, followed by the cytochrome b (cytb) gene 
(~23%) (Appendix S3).
5  | THE 5-  LE VEL A SSAY VALIDATION 
SCHEME
To enable standardized assay validation and reporting in the future, 
we assigned the assay- specific variables to 14 thematic blocks such 
as “in silico analysis,” “PCR,” or “extensive field testing of environ-
mental samples” (Table 3, Figure 1). Each of the variable blocks con-
tains between three and 26 variables (Appendix S1). Some of the 
variable blocks summarize basic practices (e.g., “in silico analysis”) 
while others describe advanced assay validation (e.g., “detection 
probability estimation from statistical modeling”). To simplify the 
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reporting of an assay's validation level in the future, the blocks were 
placed on a five- level scale enabling the categorization of assays 
from Level 1 (incomplete) to Level 5 (operational), and the interpre-
tation of associated field study results (Figure 1). The scale is addi-
tive, which means for an assay to be placed at Level 3, it must fulfill 
the reporting requirements of Levels 1, 2, and 3. Level 1 (incomplete) 
summarizes assays for which basic in silico analysis, target tissue 
testing, and general information regarding PCR were reported. Level 
2 (partial) assays were characterized by comprehensive reporting 
of PCR conditions and in vitro testing on closely related nontarget 
species. For assays placed at Level 3 (essential), the target organism 
was successfully detected from an environmental sample and the 
specifics of DNA extraction and concentration of eDNA from the 
environmental sample (i.e., filtration, precipitation) were reported. 
The LOD, extensive field testing, and in vitro testing on co- occurring 
nontarget species were the variable blocks specifically associ-
ated with Level 4 (substantial). At Level 5 (operational), the assay 
has been subjected to comprehensive specificity testing, detection 
probability estimates from statistical modeling, and investigations of 
ecological and physical factors potentially influencing eDNA in the 
environment (Table 3, Figure 1).
The placement of assays on this 5- level scale is not straight-
forward, since each of the 14 variable blocks contains variables 
associated with either rudimentary or substantial validation and re-
porting. For instance, the thematic block “concentration of eDNA 
from environmental sample” contains the variable “volume/weight 
of environmental sample,” which was reported for almost all assays, 
but also contains “pressure used for filtration,” which was rarely re-
ported and/or measured. Therefore, a minimum criterion was intro-
duced for each variable block functioning as proof of validation and 
ensuring standardized placement of assays on the validation scale. 
For example, “detection from an environmental sample” was used 
as evidence that some validation had been undertaken in the block 
“detection obtained from environmental samples” (Table 3). To reach 
a level on the validation scale, an assay must fulfill all minimum re-
porting criteria for that level and any preceding levels.
Based on this classification, the results (detected vs. not de-
tected) obtained from eDNA assays become directly interpretable: 
when Level 1 or Level 2 assays are applied to environmental samples 
without any further validation steps, it is impossible to tell whether 
the target species is present or absent independent of the PCR re-
sult. Amplifications with a Level 3 assay can be interpreted as “tar-
get is likely present”; however, nonamplifications are inconclusive. 
When Level 4 and Level 5 assays do not lead to amplification, the 
target is likely absent. Positive PCR results at Level 4 and 5 mean 
that the target species is almost certainly present (Figure 1).
For a quantitative analysis of reporting practices, we calculated a 
total scoring percentage and a block scoring percentage for each 
assay. The total scoring percentage was defined as the proportion 
of the 104 binary variables which were reported. For each of the 
14 blocks, the block scoring percentage was calculated by dividing 
the number of variables tested/reported by the complete set of 
variables associated with the block. Both calculations included only 
variables relevant to the applied methods (e.g., for assays using fil-
tration, precipitation variables were omitted; see Box 1 e.g., assays).
Of the 546 assays analyzed, the majority (30%) were classed as 
Level 1. Of the remainder, 15% (N = 83) did not fulfill the minimum 
criteria necessary to reach Level 1, and no assay reached Level 5 
(Figure 1 and Figure 2a). Newer assays published after 2016 were 
more likely to reach Level 4, and the percentage of assays failing to 
reach Level 1 gradually declined since 2014 (Figure 2b). Generally, 
the total scoring percentage for all variables associated with a level 
increased from Level 0 to Level 4, but its variation was nonuniform 
with most outliers observed at Level 2 (Figure 2c). Assays not reach-
ing Level 1 exhibited scoring percentages between ~20% and ~55%, 
clearly showing the difference between incomplete and partially 
TA B L E  3   The thematic variable blocks of the 5- level validation 
scale and their respective minimum criteria
Validation 
level Variable blocks Minimum criteria
Level 1 In silico analysis Target species
Target tissue testing Target tissue
Target tissue PCR Primer (and probe) 
sequence
Level 2 Comprehensive 
reporting of PCR 
conditions
DNA extract volume 
in PCR
In vitro testing on 
closely related 
nontarget species
Any in vitro nontarget 
testing
Level 3 Extraction method 
performed on eDNA 
samples
Method of extraction
Concentration of eDNA 
from environmental 
sample
Filter type or 
precipitation chemicals
Detection obtained from 
environmental samples
Detection from an 
environmental sample 
(artificial or natural 
habitat)
Level 4 Limit of Detection (LOD) LOD determined
Extensive field testing of 
environmental samples
Multiple locations or 
multiple samples
In vitro testing on co- 
occurring nontarget 
species
Any advanced in vitro 
testing
Level 5 Comprehensive 
specificity testing
Non- co- occurring/
closely related species 








ecological and physical 
factors influencing 
eDNA in the 
environment
Any factor influencing 
eDNA in the 
environment tested
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validated assays, which did not achieve higher levels due to one or 
several missing validation step(s). Generally, variables associated 
with lower levels on the validation scale were more likely to be re-
ported or tested. Nevertheless, some variables (e.g., “haplotypes of 
target tissue” or “pressure used for filtration”) were addressed by 
fewer than 10% of assays (Figure 2d).
The rigor of the minimum criteria was evaluated by tallying the 
not achieved/reported cases. Specifically, 62 assays did not reach 
Level 1 because the targeted species sequence(s) used in primer 
design were not reported, which is a prerequisite for this level. 
Eight assays did not report the primer sequence. The lack of tar-
get detection from an environmental sample and omission of filter 
type or precipitation chemicals were the most restrictive criteria 
and were not fulfilled by 80 and 43 assays, respectively, most of 
which were exclusively used for tissue tests (Figure 2e). For assays 
ranked at Levels 2 and 3, there was agreement between the intui-
tive assay rating provided by the recorder and that assigned by the 
objective criteria. For assays placed at Level 1 following objective 
criteria, authors tended to be more liberal and rated them one or 
two levels higher (Appendix S4). Finally, a classification tree analy-
sis (De’Ath & Fabricius, 2000) was carried out to identify common 
characteristics of assays placed at each level of the validation scale 
(Appendix S5). Most assays failing to reach Level 1 showed dis-
tinctly low levels of in silico validation. This was also true for most 
Level 1 assays (N = 103), albeit these showed higher levels of target 
tissue validation (Figure 3). On the other end of the spectrum, Level 
4 assays were characterized by substantial testing or reporting for 
in vitro testing, field sample processing, LOD determination, PCR, 
and field testing.
6  | CONCLUSIONS AND OUTLOOK
The validation scale and reporting standards developed here are an 
inclusive set of guidelines for targeted eDNA assays. They can facili-
tate communication between the scientific community, commercial 
providers, and government agencies and provide guidelines regard-
ing the application of previously published assays or the develop-
ment and publication of new assays (Sepulveda et al., 2020). One 
needs to acknowledge that a strict standardization of eDNA assays 
will not be possible due to applications for manifold taxa in diverse 
ecosystems combined with technological advances. By checking 
which of the 122 validation variables have been addressed, it is 
possible to identify both available and missing information needed 
to successfully develop or reuse an assay. The level of validation 
required for successful routine species monitoring will also differ 
on a case- by- case basis. For example, the T. cristatus assay was not 
placed on Level 5 of the validation scale (in part due to lack of re-
porting), but was still approved as an official survey method in the 
UK. As a general recommendation, authors should report as much 
information as possible on the conducted validation steps, either 
in the main text or in the supplementary material. Additionally, de-
velopers should consult existing guidelines for best practices along 
the validation workflow prior to assay design and fieldwork (Bustin 
et al., 2009; Goldberg et al., 2016; Klymus et al., 2019; MacDonald & 
Sarre, 2017). To make the validation process accessible, we provide 
a checklist in Appendix S1. Furthermore, a website (https://edna- 
valid ation.com) was created to summarize the cornerstones of the 
validation process and the validation scale. This website will func-
tion as a curated repository for newly developed assays and authors 
F I G U R E  1   An overview of the 5- level validation scale. For each of the levels (incomplete to operational), the main accomplishments in 
the validation process and an appropriate interpretation of results are provided
assay designed








assay tested on eDNA 
samples
positive detections obtained




Limit of Detection (LOD) 
established
extensive field testing and in




detection probabilities  
estimated by statistical 
modelling
comprehensive specificity 












Levels 1 and 2
impossible to tell if target is present or absent
Level 3
not detected: impossible to tell if target is 
present or absent
detected: target is likely present if 
• field negative controls return negative
• eDNA-appropriate laboratory 
• positive detections are sequenced
Levels 4 and 5
not detected: target likely absent, assuming 
appropriate timing and replication in 
sampling; Level 5 provides the probability of 
species presence despite negative results
detected: target very likely present
Interpretation of Results
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Box 1 Examples of assays rated at Levels 0– 4. The vertical tile plot shows which of the minimum criteria the assay 
fulfills (yellow tiles), and the bar chart gives the scoring percentage (i.e., the proportion of variables that were tested 
or reported) for each of the variable blocks. Bars are colored according to the score obtained from a block with dark 
purple coding for “no validation” and yellow coding for “comprehensive validation.”
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are encouraged to enter all 122 variables and the minimum criteria 
to rank assays and calculate their scoring percentages on the valida-
tion scale. The website will also serve as a living document when 
improvements in technology and/or our understanding of eDNA in 
the environment advance.
The 5- level validation scale designed here provides an over-
view of the capabilities and uncertainties of targeted eDNA as-
says. However, the binary data entry system cannot replace a 
close check of previous publications as it does not always allow a 
qualitative assessment. Details for validation variables are often 
spread across different sections in a publication or ambiguously 
displayed. Thus, the checklist can be used as a standard reporting 
guideline for targeted eDNA assays. It should be emphasized 
that for specific research questions and associated publications, 
minimal validation efforts may be sufficient. Nevertheless, thor-
ough validation is needed to reduce uncertainties and overcome 
the limitations associated with eDNA- based species monitoring. 
Furthermore, it is important that practitioners consider how an 
assay can be modified (e.g., using different PCR reagents) and 
whether this changes its validation level.
The successful application of targeted eDNA assays for routine 
species detection and monitoring largely depends on the scientific 
community and the industry providing eDNA services. Laboratories 
participating in ring tests such as that proposed for metabarcoding 
F I G U R E  2   The main outcomes of the meta- analysis based on 546 assays from 327 publications are presented in panels a– e. Assay 
classification is based on the minimum criteria presented in Figure 1. Level 0 codes for assays that did not reach Level 1 on the validation 
scale. The color coding is consistent for all panels: Level 0 (gray), Level 1 (dark purple), Level 2 (blue), Level 3 (turquoise), Level 4 (green), and 
Level 5 (yellow). Panel (a) shows the distribution of assays across levels of the validation scale. Panel (b) displays the percentage of assays 
(N = 546) rated Level 0 to 4 that have been published each year since 2003. Panel (c) summarizes variable reporting per assay level. Panel (d) 
shows the percentage of assays reporting a specific variable (color- coded according to level). Panel (e) shows the minimum criteria necessary 
to reach each level of the validation scale, and the percentage of Level 0– 4 assays that did not report these. All variable abbreviations are 
listed in Appendix S1
F I G U R E  3   Classification tree analysis identifying the criteria distinguishing assays at different levels of the validation scale. The 
conditions along the branches show the criteria on which the dataset is split. Numbers in colored leaves show the validation level of the 
assays in the respective leaf. Numbers below the leaves represent the number of assays per validation level, summarized inside an individual 



























47  2  0  1  1
9%
16  3  2  0  0
4%
1  103  0  9  1
21%
0  22  0  0  0
4%
0  0  7  0  0
1%
1  3  51  0  0
10%
0  3  14  2  0
3%
6  0  0  14  0
4%
2  3  0  78  0
15%
6  0  1  47  0
10%
0  9  0  0  0
2%
2  0  6  1  1
2%
0  9  1  2  5
3%











12  |     THALINGER ET AL.
(Blackman et al., 2019) can facilitate consensus on analysis stan-
dards. For now, assay developers must respond to queries and help 
troubleshoot reproducibility issues. Such engagement will facilitate 
the application of targeted eDNA assays by other users and out-
side their original geographic scope or academic context. Finally, it 
is necessary for both the scientific community and the commercial 
laboratories to communicate realistic applications and limitations to 
end- users, as often an assay is not bad per se, but simply unsuitable.
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